Montelukast Prescribing at CLAPHAM PARK GROUP PRACTICE
Cromoglycate, leukotriene and phosphodesterase type-4 inhib | Respiratory System
Items (12m)
468
Total Quantity
17.1K
NHS Cost
£859
vs National Avg
-31.7%
CLAPHAM PARK GROUP PRACTICE prescribed 468 items of Montelukast over the last 12 months at a cost of £859 to the NHS. This is 31.7% below the national average prescribing rate. Montelukast is classified under Cromoglycate, leukotriene and phosphodesterase type-4 inhib in the BNF.
Monthly Prescribing Trend
Jun 2026
29
Jun 2026
39
Jun 2026
59
Jun 2026
28
Jun 2026
38
Jun 2026
45
Jun 2026
30
Jun 2026
45
Jun 2026
40
Jun 2026
32
Jun 2026
43
Jun 2026
40
Prescribing Details
| Total Items | 468 |
|---|---|
| Total Quantity | 17,080 |
| Total NHS Cost | £859 |
| Presentations | 4 different forms |
| vs National Average | -31.7% |
Montelukast Prescribing Comparison
| This practice | 468 items |
|---|---|
| National average per practice | 685 items |
| Difference | -31.7% vs national average |
Explore More
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.